Expert Statement: Tom Wilson, Pfizer
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statements
Expert Statement: Davuluri Saharsh Rao, Neuland Labs
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Federico Pollano, Rentschler
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Prasad Raje, LGM Pharma
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Gordon Bates, Lonza
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Kenneth N. Drew, Flamma
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Ludwig de Mot, EuroAPI
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Russel Miller, Enzene
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Frank Wegener, ESIM Chemicals
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: David McErlane and Aris Gennadios, Catalent
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Gavin Murdoch, Abzena
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Flow Chemistry
Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this technology in their industry sector.
Expert Statement: Andreas Woschek, Executive Vice President Chemicals, Helm
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Patrick Barthels, CSO and Hartmut Kunz, CFO, Oqema
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Gerd Bergmann, Chairman of the Managing Board, Nordmann
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Thomas Dassler, Managing Director, Häffner
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Christopher Erbslöh, Managing Director, C.H. Erbslöh
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Neville Prior, Group Chairman, Cornelius Group
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Felix Thalmann, CEO, BÜFA Group
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Robert Späth, Managing Partner, CSC Jäklechemie
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Hans Joachim Müller, Group CEO, Azelis
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Christian Kohlpaintner, CEO, Brenntag
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Thorsten Harke President, Harke Group
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
